Clozel JP - Search Results

1

Ro 40-5967, in contrast to diltiazem, does not reduce left ventricular contractility in rats with chronic myocardial infarction.

Véniant M, Clozel JP, Hess P, Wolfgang R. Véniant M, et al. Among authors: clozel jp. J Cardiovasc Pharmacol. 1991 Feb;17(2):277-84. doi: 10.1097/00005344-199102000-00014. J Cardiovasc Pharmacol. 1991. PMID: 1709233

2

Hemodynamic profile of Ro 40-5967 in conscious rats: comparison with diltiazem, verapamil, and amlodipine.

Véniant M, Clozel JP, Hess P, Wolfgang R. Véniant M, et al. Among authors: clozel jp. J Cardiovasc Pharmacol. 1991;18 Suppl 10:S55-8. J Cardiovasc Pharmacol. 1991. PMID: 1725005

3

Effects of two angiotensin converting enzyme inhibitors and hydralazine on coronary circulation in hypertensive rats.

Clozel JP, Véniant M, Hess P, Sprecher U. Clozel JP, et al. Hypertension. 1991 Oct;18(4 Suppl):II8-14. doi: 10.1161/01.hyp.18.4_suppl.ii8. Hypertension. 1991. PMID: 1833328

4

The structurally novel Ca2+ channel blocker Ro 40-5967, which binds to the [3H] desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat hearts.

Clozel JP, Véniant M, Osterrieder W. Clozel JP, et al. Cardiovasc Drugs Ther. 1990 Jun;4(3):731-6. doi: 10.1007/BF01856562. Cardiovasc Drugs Ther. 1990. PMID: 1963792

5

Effects of Ro 40-5967, a new calcium antagonist, and enalapril on cardiac remodeling in renal hypertensive rats.

Véniant M, Clozel JP, Heudes D, Banken L, Ménard J. Véniant M, et al. Among authors: clozel jp. J Cardiovasc Pharmacol. 1993 Apr;21(4):544-51. doi: 10.1097/00005344-199304000-00006. J Cardiovasc Pharmacol. 1993. PMID: 7681898

6

Acute hemodynamic effects of ciprokiren, a novel renin inhibitor, in sodium-depleted dogs.

Clozel JP, Véniant M, Sprecher U, Fischli W. Clozel JP, et al. J Cardiovasc Pharmacol. 1995 Oct;26(4):674-7. doi: 10.1097/00005344-199510000-00025. J Cardiovasc Pharmacol. 1995. PMID: 8569232

7

Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats.

Karam H, Heudes D, Hess P, Gonzales MF, Löffler BM, Clozel M, Clozel JP. Karam H, et al. Among authors: clozel jp, clozel m. Cardiovasc Res. 1996 Feb;31(2):287-95. Cardiovasc Res. 1996. PMID: 8730406

8

Renal vascular and biochemical responses to systemic renin inhibition in dogs at low renal perfusion pressure.

Clozel JP, Véniant MM, Qiu C, Sprecher U, Wolfgang R, Fischli W. Clozel JP, et al. J Cardiovasc Pharmacol. 1999 Nov;34(5):674-82. doi: 10.1097/00005344-199911000-00008. J Cardiovasc Pharmacol. 1999. PMID: 10547083

9

Chronic endothelin receptor blockade prevents renal vasoconstriction and sodium retention in rats with chronic heart failure.

Ding SS, Qiu C, Hess P, Xi JF, Clozel JP, Clozel M. Ding SS, et al. Among authors: clozel jp. Cardiovasc Res. 2002 Mar;53(4):963-70. doi: 10.1016/s0008-6363(01)00558-2. Cardiovasc Res. 2002. PMID: 11922906

10

Combination of low-dose valsartan and enalapril improves endothelial dysfunction and coronary reserve in Nomega-nitro-L-arginine methyl ester-treated spontaneously hypertensive rats.

de Gasparo M, Hess P, Clozel M, Persohn E, Roman D, Germann PG, Clozel JP, Webb RL. de Gasparo M, et al. Among authors: clozel jp. J Cardiovasc Pharmacol. 2002 Nov;40(5):789-800. doi: 10.1097/00005344-200211000-00017. J Cardiovasc Pharmacol. 2002. PMID: 12409988

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters